 The stock price of Avid Bioservices, a contract development and manufacturing company for biopharmaceutical products, has surged 48 in a month twenty-one trading days, while it is up a solid 19 in a week. The recent rise can be attributed to CDMOs inclusion in the SP SmallCap 600 index. 